Nazal Liquid
FDA Label NDC 49873-057

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Sato Pharmaceutical Co., Ltd. for the product Nazal (NDC 49873-057). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, warnings, otc - do not use, otc - ask doctor, otc - when using, otc - stop use, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

Active ingredients  
Naphazoline hydrochloride 0.05%

Otc - Purpose

Purpose    Nasal decongestant

Indications & Usage

Uses for the temporary relief of nasal congestion due to the common cold, hay fever, or associated with sinusitis

Warnings

Warnings
For external use only

Otc - Do Not Use

Do not use
■for more than 3 days
■in children under 12 years of age because it may cause sedation if swallowed

Otc - Ask Doctor

Ask a doctor before use if you have
■heart disease
■high blood pressure
■thyroid disease  ■diabetes
■difficulty in urination due to enlargement of the prostate gland

Otc - When Using

When using this product
■do not exceed recommended dosage
■if may cause temporary discomfort such as burning, stinging, sneezing, or an increase in nasal discharge
■the use of this container by more than one person may spread infection
■use only as directed
■frequent or prolonged use may cause nasal congestion to recur or worsen

Otc - Stop Use

Stop use and ask a doctor if
■symptoms persist

Otc - Pregnancy Or Breast Feeding

If pregnant or breast-feeding, ask a health professional before use.

Otc - Keep Out Of Reach Of Children

Keep our of reach of children.  In case of accidental overdose, get medical help or contact a Poison Control Center right away.

Dosage & Administration

Directions
Adults and children 12 years of age and older - 1 or 2 sprays in each nostril not more often than every 6 hours
Children under 12 years of age -  do not give unless directed by a doctor

Other Safety Information

Other information  
■container is filled to proper level for best spray action

Inactive Ingredient

Inactive ingredients
benzalkonium chloride, citric acid, dibasic potassium phosphate, fragrance, monobasic potassium phosphate, simethicone, sodium chloride, water

Package Label.Principal Display Panel

nazalPDP.jpg

nazalcart.jpg

Carton (Nazalcart)

Carton (Nazalcart)

* Please review the disclaimer below.